7 companies

CanSino Biologics

Market Cap: HK$9.5b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$23.38

7D

0.8%

1Y

-45.1%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$122.9b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$514.00

7D

5.7%

1Y

38.8%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$55.5b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$52.05

7D

3.2%

1Y

150.2%

WuXi XDC Cayman

Market Cap: HK$70.3b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$55.55

7D

4.2%

1Y

-1.2%

Innovent Biologics

Market Cap: HK$156.6b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

1801

HK$89.95

7D

1.1%

1Y

0.9%

Akeso

Market Cap: HK$91.7b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$99.50

7D

12.6%

1Y

-33.3%

InSilico Medicine Cayman TopCo

Market Cap: HK$26.9b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

New

3696

HK$47.06

7D

8.9%

1Y

n/a